Halozyme Therapeutics
HALO
£47.87
Share price
-3.04%
Change (1 day)
46.40%
Change (1 year)
Categories
Earnings for Halozyme Therapeutics (HALO)
Earnings in 2024 (TTM): £0.43 Billion
According to Halozyme Therapeutics's latest financial reports the company's current earnings are £1.01 Billion. , an increase over its 2023 earnings that were of £0.26 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Halozyme Therapeutics from 2002 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | £0.43 B | 59.94% |
| 2023 | £0.26 B | 39.94% |
| 2022 | £0.19 B | 0.16% |
| 2021 | £0.19 B | 92.2% |
| 2020 | £0.10 B | -278.96% |
| 2019 | -£55.91 Million | -9.45% |
| 2018 | -£61.74 Million | -229.51% |
| 2017 | £47.66 M | -160.48% |
| 2016 | -£78.81 Million | 216.03% |
| 2015 | -£24.94 Million | -52.86% |
| 2014 | -£52.91 Million | -18.09% |
| 2013 | -£64.59 Million | 55.88% |
| 2012 | -£41.44 Million | 169.94% |
| 2011 | -£15.35 Million | -63.44% |
| 2010 | -£41.98 Million | -7.19% |
| 2009 | -£45.23 Million | 15.91% |
| 2008 | -£39.03 Million | 83.89% |
| 2007 | -£21.23 Million | 78.1% |
| 2006 | -£11.92 Million | 16% |
| 2005 | -£10.28 Million | 45.24% |
| 2004 | -£7.08 Million | 682.42% |
| 2003 | -£0.91 Million | 1659.12% |
| 2002 | -£0.06 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | £23.61 M | -94.52% | 🇺🇸 USA |
 | £9.81 B | 2,176.01% | 🇺🇸 USA |
 | -£0.46 Billion | -206.44% | 🇺🇸 USA |
 | £8.59 B | 1,894.68% | 🇺🇸 USA |
 | £6.14 B | 1,325.52% | 🇫🇷 France |
 | £13.49 B | 3,030.68% | 🇺🇸 USA |